Company intelligence / Profile preview

Chereso Lifesciences

Panchkula, Haryana, Indiachereso.net ↗

Ownership: Private
Development stage: Commercial

Overview

Chereso Lifesciences manufactures and exports standardized herbal extracts and nutraceutical products with a focus on women’s health, metabolic disorders like diabetes, weight management, immunity support, and men’s health. Their flagship product "Furocyst" has been featured in the media for supporting women with PCOS. The company holds over thirty patents related to their innovations. No clinical trial data or pharmaceutical regulatory approvals found; products are commercialized as supplements.

Therapeutic areas: EndocrinologyImmunologyMen's Health
Modalities: Small molecule (plant-derived)Herbal extractNutraceutical product
Industry: Food & Nutrition

Drug pipeline

1 asset

furocyst

Commercial

Indications: Polycystic ovary syndrome

Beyond the preview

Go deeper on Chereso Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chereso Lifesciences.

Explore the full profile